FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Clears Quidels Sofia 2 Lyme Immunoassay

[ Price : $8.95]

FDA clears a Quidel 510(k) for its Sofia 2 Lyme Fluorescent Immunoassay and its use with the Sofia 2 Fluorescent Immunoassay Analy...

Sunovion Gets Rejection Letter on ADHD Drug

[ Price : $8.95]

FDA issues Sunovion Pharmaceuticals a complete response letter rejecting its NDA for dasotraline, a novel dual-acting dopamine and...

Bayer Hemophilia Therapy Jivi Approved

[ Price : $8.95]

FDA approves Bayers Jivi for the routine prophylactic treatment of hemophilia A in previously treated adults and adolescents 12 ye...

Pilot Meetings for Innovative Trial Designs

[ Price : $8.95]

Federal Register notice: FDA announces a pilot meeting program to allow sponsors to discuss the use of complex innovative trial de...

Insys Gets Fast Track for Potential EpiPen Rival

[ Price : $8.95]

FDA grants Insys Therapeutics a fast track designation for its epinephrine nasal spray as an investigational treatment for anaphyl...

Pull Shared System REMS Guidance: NACDS

[ Price : $8.95]

Chain drug stores urge FDA to withdraw a draft guidance on waivers for single, shared system REMS, and other stakeholders also cri...

CDER Statisticians Tout Flexible Trial Designs

[ Price : $8.95]

An online CDER post describes work of Center statistical researchers in developing complex innovative clinical trial designs.

FDA Modernizing Regulation Approach: Gottlieb

[ Price : $8.95]

FDA commissioner Scott Gottlieb says the agency is modernizing its approach to medical product regulation to support innovation in...

Sexual Enhancement Product Permanent Injunction

[ Price : $8.95]

The New Jersey federal court approves a permanent injunction sought by FDA against several companies and their executives charged ...

Auris Medical Get FDA Buy-in for Pivotal Trial

[ Price : $8.95]

FDA approves Auris Medicals proposed choice of primary and secondary efficacy endpoints for a pivotal Phase 3 trial of AM-111 (bri...